chemotherapy

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

chemotherapy
Sep 14, 2024, 15:38 | Insight
ESMO24 Day 1 highlights by Tom Powles
The ESMO Congress 2024 (ESMO24) is taking place from 13-17 September 2024, in Barcelona. ESMO24…
Sep 13, 2024, 08:15 | Blog
Enrique Soto: Time toxicity among older patients with cancer
Enrique Soto shared a post on X, about their manuscript published in Supportive Care in…
Sep 12, 2024, 20:43 | Blog
Carmen Uscatu: Turning suffering into a character
Carmen Uscatu, Founding Member, President at Give Life (Dăruiește Viață), shared a post on LinkedIn: ''She…
Sep 12, 2024, 08:56 | Blog
Miriam Mutebi: A tragic scene far too common across Africa
Miriam Mutebi shared on Linkedin: ' 'Make it Stop!' A friend interested in training to…
Sep 10, 2024, 13:49 | Blog
The Institute of Cancer Research - Lucas’ Legacy to help fund research into childhood brain tumours
The Institute of Cancer Research shared on LinkedIn: "'I’m so sorry Lucas that I couldn’t protect…
Sep 10, 2024, 00:19 | Blog
Miriam Mutebi: In many African cultures cancer is referred to as a 'wound with which we will be buried'
Miriam Mutebi shared a post on LinkedIn: ''In many African cultures, the language used to…
Sep 9, 2024, 13:23 | Immune Oncology,Oncolibrary
Immunotherapy vs Chemotherapy: Success Rates, Side Effects, Costs Compared
When comparing immunotherapy vs chemotherapy, it's important to understand how these cancer treatments work differently.…
Sep 9, 2024, 13:17 | Cancer Types
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Small bowel cancer, often referred to as small intestine cancer, is a rare but serious…
Sep 9, 2024, 11:46 | Insight
Association between TIL and survival in patients with MBC receiving first-line chemotherapy
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a paper by Daniel Stover…
Sep 9, 2024, 09:55 | Societies
Insights from WCLC24 by Chul Kim
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 9, 2024, 09:04 | Societies
Insights from WCLC24: Ana I. Velázquez Mañana’s Key Highlights
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 7, 2024, 19:36 | Insight
A year of treatment with an ADC has proven highly effective in preventing stage 1 HER2-positive breast cancer from recurring - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared the following on LinkedIn: “A year of treatment with a medicine…
Sep 6, 2024, 13:23 | Dialogues
Liposarcoma Advances and Challenges - Sarcoma Talk #9 with Vinayak Venkataraman
In this edition of Sarcoma Talk on OncoDaily, Dr. Vinayak Venkataraman, a medical oncologist from…
Sep 6, 2024, 12:35 | Blog
Olubukola Ayodele: Every breast cancer journey is unique, and seeking advice from an oncologist is vital in navigating a diagnosis
Olubukola Ayodele posted on LinkedIn: “I recently read about Elle Macpherson and her journey with breast…
Sep 6, 2024, 11:25 | Insight
Paolo Tarantino: Interesting RWA of outcomes with chemotherapy in HR+/HER2- MBC
Paolo Tarantino shared a post by ESMO Open on X, adding: "Interesting real world analysis…
Sep 3, 2024, 16:59 | Blog
Zainab Shinkafi-Bagudu: Introducing the Patient Access to Care program
Zainab Shinkafi-Bagudu shared a post on LinkedIn: "Introducing the Patient Access to Care (PACE) program—an…
Sep 2, 2024, 18:35 | Blog
Dr. Owen O'Connor: The Vessel of Hope for Peripheral T-Cell Lymphoma Braves the Storm and Forges Ahead Fearlessly
MediaMedic made the following blog on LinkedIn: "In order to further improve the diagnostic and treatment…
Sep 2, 2024, 17:34 | Blog
Elisabetta Bonzano: Improved efficacy outcomes in early-stage TNBC neoadjuvant ICI therapy
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X: "Neoadjuvant Immune Checkpoint…
Sep 2, 2024, 09:38 | Insight
Antonio Passaro: EMA approves amivantamab in combination with chemo for treatment of advanced EGFR-mutated NSCLC after Osimertinib
Antonio Passaro, shared a post on X: "EMA approves amivantamab in combination with chemo for…
Sep 1, 2024, 16:54 | Blog
Paulo Luz: AI for Patients with HER2+ Breast Cancer - HER2pCRPredict
Paulo Luz shared a post on LinkedIn: ''AI for Patients with HER2+ Breast Cancer -…
Aug 28, 2024, 18:36 | Blog
Miriam Mutebi: Chemotherapy is a Vital Yet Misunderstood Cancer Treatment
Miriam Mutebi shared a post on LinkedIn: "Chemotherapy, a vital cancer treatment option, offers hope to…
Aug 27, 2024, 21:52 | Blog
David Gandara: Jonathan Riess about impact of baseline positive vs negative plasma ctDNA
David Gandara, Co-Director-Center for Experimental Therapeutics at UC Davis Comprehensive Cancer Center, shared a post…
Aug 27, 2024, 21:42 | Insight
Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: “This new Journal of the National…
Aug 27, 2024, 21:11 | Positive
Miriam Mutebi: Find humor even in tough times
Miriam Mutebi shared a post on LinkedIn: "My dad has often reminded me to find…
Aug 26, 2024, 17:07 | Blog
Living Beyond Breast Cancer is partnering with Paxman Scalp Cooling to host Navigating Treatment Related Side Effects
Living Beyond Breast Cancer shared a post on LinkedIn by Paxman Scalp Cooling: "We are thrilled…
Aug 26, 2024, 16:59 | Blog
Stryder's Journey with Stage 4 High-Risk NeuroBlastoma - St. Baldrick's Foundation
St. Baldrick's Foundation shared a post on LinkedIn: "When Stryder was diagnosed with stage 4 high-risk…
Aug 24, 2024, 11:15 | Insight
Jill Feldman: Exciting news for the EGFR lung cancer community
Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post by Jill Feldman on…
Aug 24, 2024, 10:51 | Insight
Shahrin Ahmed: High health care utilization and poor survival rate in older adults with AML
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: “Older…
Aug 22, 2024, 20:35 | Insight
Oral Cannabis for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting
The final results of the study on Oral Cannabis Extract for the secondary prevention of…
Aug 21, 2024, 16:13 | Blog
New Friends of Cancer Research on Alignment of methodologies analyzing real-world data
Friends of Cancer Research shared on LinkedIn: "New Friends of Cancer Research manuscript in JCO Clinical…
Aug 21, 2024, 14:40 | Blog
Erman Akkus: Our review on platinum chemotherapy for metastatic castration-resistant prostate cancer
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a post on…
Aug 21, 2024, 13:23 | Blog
Amol Akhade: What after chemotherapy plus IO in non oncogene addicted NSCLC?
Amol Akhade shared on X: "What after chemotherapy plus IO in non oncogene addicted NSCLC?…
Aug 20, 2024, 14:53 | Blog
Miriam Mutebi: How we can embrace community-centered palliative care that reflects African values and realities
Miriam Mutebi shared on LinkedIn: "This weekend I spent some time thinking about how we…
Aug 19, 2024, 16:12 | Blog
Celebrating 25 years of impact - St. Baldrick's Foundation
St. Baldrick's Foundation shared a post on X: "As we celebrate 25 years of impact, we're…
Aug 19, 2024, 08:12 | Insight
Vivek Subbiah: How does PARP Inhibitor affect BARD1-Mutated Neuroblastoma?
Vivek Subbiah shared on LinkedIn: "BARD1 = encodes the BRCA1-associated RING domain 1 protein which forms…
Aug 18, 2024, 14:58 | Insight
Real data of LARCT-US Swedish prospective cohort study on high risk rectal cancer
Hyun Kim, Radiation Oncologist at Wash University Radiation Oncology, shared a post on X about…
Aug 16, 2024, 19:33 | Blog
Mark Lewis: Inigo Montoya would be proud
Mark Lewis shared a post on X: “A patient with a complete response to cancer…
Aug 16, 2024, 12:43 | Dialogues
Shubh Goel on Niagara Trial Results and AstraZeneca’s Global Impact
Shubh Goel, the VP and Head of Immuno-Oncology and GI Tumors at AstraZeneca, joins host…
Aug 14, 2024, 14:20 | Blog
Abeid Athman Omar: Historic day at the Kenyatta University Teaching, Referral and Research Hospital
Abeid Athman Omar, Clinical Oncology Specialist at Kenyatta University Teaching, Referral and Research Hospital, shared…
Aug 14, 2024, 07:33 | Insight
Olanzapine as antiemetic prophylaxis in chemotherapy
Elisa Agostinetto shared on X: "Olanzapine as antiemetic prophylaxis in chemotherapy. In this randomized phase…
Aug 12, 2024, 22:43 | Dialogues
The Founding Sarcoma UK - Sarcoma Talk #7 with Roger Wilson
Roger Wilson, founder of Sarcoma UK, joins Shushan Hovsepyan, pediatric oncologist and editor-in-chief, to discuss…
Aug 12, 2024, 22:14 | Blog
Exercise reduces CIPN during Chemotherapy
Alessandro Samuelly, Medical oncologist at the University of Turin, shared on X: "Great results from…
Aug 12, 2024, 07:28 | Dialogues
Immunotherapy in Soft Tissue - 5 min Sarcoma Talk #6 with Sandra D'Angelo
In the new episode of "5 Minute Sarcoma Talk", Dr. Shushan Hovsepyan, the Editor-in-Chief of…
Aug 12, 2024, 01:27 | Blog
Michael Ong received $2.4M for metastatic prostate cancer - CCTG
The Canadian Cancer Trials Group shared on X: "Congratulations to Dr Michael Ong, who has received…
Aug 11, 2024, 19:47 | Blog
Praveen Kumar Marimuthu: Phase 2 trial Carboplatin, Pemetrexed, Cetuximab for advanced NSCLC
Praveen Kumar Marimuthu, Final year Medical Oncology Trainee at CMC Vellore, shared on X: "OPEN FOR…
Aug 10, 2024, 12:57 | Insight
MD Anderson Research Highlights
Featuring cell biology insights, new targets to prevent dysphagia, improved treatments for advanced cancers and…
Aug 10, 2024, 06:37 | Insight
Yüksel Ürün: Exploring the balance of taking breaks from chemotherapy
Yüksel Ürün shared on X: "Exploring the balance of taking breaks from chemotherapy. Can it…
Aug 6, 2024, 03:11 | Blog
Periods, Fertility and Breast Cancer: Separating Fact from Fiction With Monika Pansari
Monika Pansari, Senior Consultant Surgical Oncologist at Fortis Hospital, shared a post on LinkedIn: "Breast cancer is…
Aug 4, 2024, 10:09 | Blog
Mark Lewis: Grateful to work with Intermountain Health on digital resources for patients undergoing chemotherapy
Mark Lewis shared on X: "Grateful to work with Intermountain Health on digital resources for…
Aug 4, 2024, 05:15 | Insight
Yüksel Ürün: U.S. FDA expands endometrial cancer indication for dostarlimab-gxly with chemotherapy
Yüksel Ürün shared on X: "U.S. FDA expands endometrial cancer indication for dostarlimab-gxly with chemotherapy.…
Jul 31, 2024, 11:47 | Insight
General tips for eating well during treatment - CA: A Cancer Journal for Clinicians
CA: A Cancer Journal for Clinicians shared on X: "Eating nutritious foods can help cancer…
Jul 30, 2024, 02:33 | Insight
Study by Sylvester Comprehensive Cancer Center Identifies Biomarker that Could Predict Whether Colon Cancer Patients Benefit from Chemotherapy
Many people with stage II or III colon cancer receive additional, or adjuvant, chemotherapy following…
Jul 29, 2024, 23:25 | Insight
Akhil Kapoor: Intensifying Chemotherapy in advanced Gastric Cancer doesn't improve survivals
Akhil Kapoor, Associate Professor and Medical Oncology at TMH Varanasi, shared a post on X:…
Jul 29, 2024, 21:28 | Insight
RWO with chemotherapy for patients who progress after PACIFIC regimen
Stephen Liu shared a post on X about a recent paper by Hayato Kawachi et al.…
Jul 29, 2024, 06:38 | Blog
Heart of a Warrior: Jennifer’s Triumphant Fight Against Cancer
Jennifer's story is a testament to strength and resilience. Faced with limited treatment options, she…
Jul 29, 2024, 02:16 | Insight
Shahrin Ahmed: A significant increase in the number of clinical trials on Non-Hodgkin's lymphoma since 2019
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: "In 2019,…
Jul 28, 2024, 10:32 | Insight
How the gut microbiome may influence chemotherapy response in urothelial carcinoma
Cancer Research Communications shared a post on X about a recent paper by Laura Bukavina et…
Jul 28, 2024, 09:00 | Insight
Muscle-Invasive Bladder Cancer with ATM, RB1, ERCC2, and FANCC mutations
Yüksel Ürün shared a post on X about a recent paper by Elizabeth Plimack et…
Jul 27, 2024, 13:56 | Insight
ASCO Rapid Recommendation Update on Management of Stage III NSCLC
Estela Rodriguez shared a paper by Megan E. Daly et al. on X, adding: “Hot Off…
Jul 27, 2024, 09:27 | Blog
Rebecca Shatsky: RSClin tool is still really underutilized by oncologists
Rebecca Shatsky shared on X: "RSClin tool is still really underutilized by oncologists to evaluate individual…
Jul 26, 2024, 19:50 | Blog
Kevin Conroy: Katherine is an incredible reminder of the 20-year impact Oncotype DX has made on breast cancer
Kevin Conroy, Chairman and CEO at Exact Sciences, shared on LinkedIn: "Our patients are at…
Jul 25, 2024, 21:01 | Blog
Caner Saygin: A testament to the fact that flow MRD is insufficient for making treatment decisions in ALL
Caner Saygin, Assistant Professor of Medicine at University of Chicago, shared a post by NEJM, on X:…
Jul 25, 2024, 00:18 | Blog
Breaking Science in Gastrointestinal Cancers with Kohei Shitara - ESMO
ESMO (European Society for Medical Oncology) shared on LinkedIn: "For ESMO members: Breaking Science in Gastrointestinal…
Jul 24, 2024, 03:52 | Insight
Piotr Wysocki: The type of immunotherapy-related adverse event impacts the outcomes of anti-cancer immunotherapy
Piotr Wysocki recently posted on LinkedIn: “Understanding the co-occurrence patterns of immune-related adverse events (irAEs) across…
Jul 24, 2024, 02:45 | Blog
Mark Lewis: Treatment almost always has to be tolerable for it to be effective
Mark Lewis shared a post on X by Mark Cuban, Entrepreneur owner of Cost Plus…
Jul 22, 2024, 23:10 | Blog
Edgardo S. Santos: The ProPhet test could help us to tailor immunotherapy beyond just PD-L1 expression
Edgardo S. Santos, Vice President of Florida Society of Clinical Oncology, shared a post on…
Jul 22, 2024, 16:08 | Stories
Too many kids are dying from the side effects of traditional chemotherapy - Children’s Cancer Institute
Children’s Cancer Institute shared on LinkedIn: "Toby was still in his mother’s womb when doctors…
Jul 21, 2024, 16:40 | Insight
Hung Trinh: FDA breakthrough designation for trial of cell-based therapy for high-risk lymphoma
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Jul 20, 2024, 12:06 | Blog
Andrew Lane: Powerful segment produced by Medical Stories on one of my brave patients at Dana-Farber with BPDCN
Andrew Lane, Associate Chief of Division of Hematologic Neoplasia at Dana-Farber Cancer Institute, shared a post…
Jul 20, 2024, 11:34 | Blog
Abhishek D. Garg: TIM3+VISTA+ macrophage subset that mediates resistance to anticancer immunotherapy and chemotherapy
Abhishek D. Garg, Head of Laboratory of Cell Stress and Immunity (CSI) at KU Leuven,…
Jul 19, 2024, 23:00 | Blog
Voice of the families. Tigist and her father - CANCaRe Africa
CANCaRe Africa shared a post on LinkedIn: ''Voice of the families. Post #13: Tigist and…
Jul 19, 2024, 13:20 | Blog
Alexios Matikas: We show for the first time the superiority of dose dense versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer
Alexios Matikas, Associate Professor of Oncology at Karolinska Institute, shared on LinkedIn: "Dose dense is…
Jul 19, 2024, 10:12 | Celebrities
Michael Douglas: The Untold Story of His Battle Against Cancer
Michael Douglas, says “My cancer has made me a free man.” Thirteen years after surviving…
Jul 19, 2024, 08:42 | Blog
Breaking Science in Gastrointestinal Cancers with Maximiliano Gelli - ESMO
ESMO - European Society for Medical Oncology shared a post on LinkedIn: "For ESMO members:…
Jul 15, 2024, 01:58 | Stories
No one is too young to have cancer - Stella H.
Colorectal Cancer Alliance shared on LinkedIn: "'A lot of people still think colorectal cancer is…
Jul 14, 2024, 05:19 | Cancer Types
What 99% of people don't know about Colorectal Cancer
Hello, welcome to our course on colorectal cancer. In this video, we'll provide an overview…
Jul 13, 2024, 20:21 | Blog
Antoni van Leeuwenhoek has been awarded with grant of 4.1 million eur
Marleen Kok shared Antoni van Leeuwenhoek's post on LinkedIn, adding: "Incredibly proud of my team…
Jul 13, 2024, 14:15 | Dialogues
I never knew how close to this disease I would eventually become - Benny Johnson’s personal story with cancer
The new issue of OncoDaily Magazine had the privilege to feature an exclusive interview with Dr.…
Jul 11, 2024, 17:37 | Blog
Myriam Chalabi: An important international study on whether high TILs can be used to safely omit chemotherapy in TNBC
Myriam Chalabi shared a post by The Netherlands Cancer Institute, on X, adding: ''Congratulation Marleen Kok…
Jul 11, 2024, 14:56 | Insight
Simona Cristea: The multi-facet process of resistance to KRAS inhibitors in pancreatic cancer
Simona Cristea, Head of Data Science at Hale Center for Pancreatic Cancer, shared a post by…
Jul 11, 2024, 13:16 | Blog
Steven O'Day about how immunotherapy stands apart from traditional chemotherapy - Agenus
Agenus shared a post on LinkedIn:  . "Did you know immunotherapy activates the body’s own…
Jul 10, 2024, 05:38 | Blog
Marleen Kok: My team will be awarded grant of 4.1 million euro from KWF Dutch Cancer Society
Marleen Kok, Associate Professor at The Netherlands Cancer Institute, shared a post on X: "Incredibly…
Jul 9, 2024, 09:41 | Insight
Rebecca Shatsky: Love my good friend Paolo Tarantino’s explanation of Her2 Ultra Low
Rebecca Shatsky shared a post by Paolo Tarantino on X, adding: “Love my good friend Paolo…
Jul 8, 2024, 04:52 | Insight
Spotlight on Alveolar soft part sarcoma - NCI
National Cancer Institute (NCI) shared a post on LinkedIn: "Alveolar soft part sarcoma (ASPS) is…
Jul 8, 2024, 01:07 | Blog
Konstantinos Kokkaliaris: Niche-centric strategies to revert aging and chemotherapy-related hematopoietic decline
Konstantinos Kokkaliaris, Junior group leader at Dr. Senckenberg Institute of Pathology, shared a post on…
Jul 5, 2024, 16:12 | Insight
Sunscreen Is Your Best Friend This Summer - Sylvester Cancer Experts
Feels good to soak up some rays by the beach or pool, but your skin…
Jul 4, 2024, 10:04 | Blog
Ajay Major: ViPOR in LBCL of NEJM by Christopher Melani et al.
Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and…
Jul 3, 2024, 01:37 | Blog
Albert Grinshpun: Another important sub-population which might enjoy life without chemo
Albert Grinshpun, Goldfarb Advanced Breast Cancer Fellow at the Breast Oncology Center of Dana-Farber Cancer…
Jul 2, 2024, 08:47 | Insight
Lecture from CCLG UK on management of chemotherapy induced pain and nausea- POINTE
Pediatric Oncology International Network for Training and Education (POINTE) shared on X: “Paediatric Haematology/Oncology Online…
Jul 1, 2024, 15:23 | Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jun 30, 2024, 16:30 | Insight
Veerle Geurts: Excellent outcome without chemotherapy for TNBC and high TILs
Veerle Geurts, PhD Candidate at The Netherlands Cancer Institute, shared on LinkedIn: “Patients with stage…
Jun 29, 2024, 13:50 | Drugs
Chemotherapy with adjuvant nivolumab versus placebo for GEJ cancer
Syed A. Ahmad, Chief of Surgical Oncology at The University of Cincinnati, made the following…
Jun 28, 2024, 14:34 | Blog
María Natalia Gandur Quiroga: Imfinzi Shows Significant Survival Benefits in NIAGARA Phase III Trial
María Natalia Gandur Quiroga shared on LinkedIn:   . "Imfinzi Shows Significant Survival Benefits in NIAGARA…
Jun 27, 2024, 14:17 | Insight
Mohit Manrao: Positive high-level results from the NIAGARA Phase 3 study with IO in MIBC
Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared on LinkedIn: “This content is…
Jun 27, 2024, 13:17 | Insight
Non-chemotherapy treatment regimen for aggressive B-cell lymphoma
Kimryn Rathmell shared on X: "Exciting news: NCI researchers and collaborators have developed a non-chemotherapy…
Jun 25, 2024, 03:11 | Blog
Eytan Ruppin: Analyzing Tumor Microenvironment using bulk transcriptomics with Machine Learning
Eytan Ruppin, Chief of the Cancer Data Science Lab of the National Institute of Health, shared…
Jun 25, 2024, 02:26 | Blog
Carmen Uscatu: Compassion means empathy in action
Carmen Uscatu, President at Give Life, shared a post on LinkedIn:         …
Jun 24, 2024, 22:56 | Blog
Giovanni Marchegiani: Perioperative modified FOLFIRINOX for pancreas cancer
Giovanni Marchegiani, Pancreas Surgeon at The University of Padua, made the following post on X:…
Jun 24, 2024, 13:43 | Blog
Kids deserve less toxic treatments - St. Baldrick’s Foundation
St. Baldrick’s Foundation posted on LinkedIn:     . “Birthdays are supposed to be a time…
Jun 24, 2024, 05:46 | Blog
Trish Boh: The Dearborn Cancer Center
Trish Boh, Executive Secretary to Executive Medical Director of Oncology Services and Directors at St. Elizabeth…
All: 239 Posts: 1 - 100
Special Coverage